HUP0002521A3 - Onium salts of paclitaxel, process for producing them and medicaments comprising the same - Google Patents
Onium salts of paclitaxel, process for producing them and medicaments comprising the sameInfo
- Publication number
- HUP0002521A3 HUP0002521A3 HU0002521A HUP0002521A HUP0002521A3 HU P0002521 A3 HUP0002521 A3 HU P0002521A3 HU 0002521 A HU0002521 A HU 0002521A HU P0002521 A HUP0002521 A HU P0002521A HU P0002521 A3 HUP0002521 A3 HU P0002521A3
- Authority
- HU
- Hungary
- Prior art keywords
- paclitaxel
- medicaments
- producing
- same
- onium salts
- Prior art date
Links
- 229930012538 Paclitaxel Natural products 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229960001592 paclitaxel Drugs 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical class O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Epoxy Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1997/010746 WO1998058927A1 (en) | 1997-06-20 | 1997-06-20 | Soluble prodrugs of paclitaxel |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0002521A2 HUP0002521A2 (hu) | 2001-06-28 |
| HUP0002521A3 true HUP0002521A3 (en) | 2002-04-29 |
Family
ID=22261122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0002521A HUP0002521A3 (en) | 1997-06-20 | 1997-06-20 | Onium salts of paclitaxel, process for producing them and medicaments comprising the same |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP1001769B1 (hu) |
| JP (1) | JP2002505682A (hu) |
| AT (1) | ATE219363T1 (hu) |
| AU (1) | AU3574097A (hu) |
| CA (1) | CA2294606A1 (hu) |
| DE (1) | DE69713526D1 (hu) |
| HU (1) | HUP0002521A3 (hu) |
| IL (1) | IL133585A0 (hu) |
| SK (1) | SK182599A3 (hu) |
| WO (1) | WO1998058927A1 (hu) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1171118A2 (en) * | 1999-04-09 | 2002-01-16 | Jessie L.S. Au | Methods and compositions for enhancing delivery of therapeutic agents to tissues |
| US6380405B1 (en) | 1999-09-13 | 2002-04-30 | Nobex Corporation | Taxane prodrugs |
| US6541508B2 (en) | 1999-09-13 | 2003-04-01 | Nobex Corporation | Taxane prodrugs |
| US6713454B1 (en) | 1999-09-13 | 2004-03-30 | Nobex Corporation | Prodrugs of etoposide and etoposide analogs |
| US6638906B1 (en) | 1999-12-13 | 2003-10-28 | Nobex Corporation | Amphiphilic polymers and polypeptide conjugates comprising same |
| MXPA03006404A (es) * | 2001-01-18 | 2004-12-02 | Upjohn Co | Composiciones quimioterapeuticas de microemulsion de paclitaxel con biodisponibilidad oral mejorada. |
| US7115565B2 (en) | 2001-01-18 | 2006-10-03 | Pharmacia & Upjohn Company | Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability |
| US7351542B2 (en) | 2002-05-20 | 2008-04-01 | The Regents Of The University Of California | Methods of modulating tubulin deacetylase activity |
| US20070172446A1 (en) | 2003-05-16 | 2007-07-26 | Intermune, Inc. | Synthetic chemokine receptor ligands and methods of use thereof |
| US7597884B2 (en) | 2004-08-09 | 2009-10-06 | Alios Biopharma, Inc. | Hyperglycosylated polypeptide variants and methods of use |
| WO2006089209A2 (en) | 2005-02-17 | 2006-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby |
| AU2008272785B2 (en) | 2007-07-03 | 2014-06-12 | Children's Hospital & Research Center At Oakland | Polysialic acid derivatives, methods of production, and uses in enhancing cancer antigen production and targeting |
| WO2009143454A2 (en) | 2008-05-22 | 2009-11-26 | Kereos, Inc. | Combination antitumor therapy |
| EP2310507A4 (en) | 2008-07-08 | 2013-03-20 | David Gladstone Inst | METHODS AND COMPOSITIONS FOR MODULATING ANGIOGENESIS |
| WO2012137225A1 (en) * | 2011-04-08 | 2012-10-11 | Sphaera Pharma Pvt. Ltd | Substituted methylformyl reagents and method of using same to modify physicochemical and/or pharmacokinetic properties of compounds |
| EP3539563A1 (en) | 2012-07-19 | 2019-09-18 | Redwood Bioscience, Inc. | Antibody specific for cd22 and methods of use thereof |
| AU2013341711A1 (en) | 2012-11-12 | 2015-05-21 | Redwood Bioscience, Inc. | Compounds and methods for producing a conjugate |
| ES2758227T3 (es) | 2013-02-15 | 2020-05-04 | Univ California | Receptor de antígeno quimérico y métodos de uso del mismo |
| JP6410790B2 (ja) | 2013-03-14 | 2018-10-24 | ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー | ミトコンドリアアルデヒドデヒドロゲナーゼ−２調節因子およびその使用方法 |
| CA2927806C (en) | 2013-11-27 | 2023-01-10 | Redwood Bioscience, Inc. | Hydrazinyl-pyrrolo compounds and methods for producing a conjugate |
| US9879036B2 (en) | 2014-02-19 | 2018-01-30 | Aviv Therapeutics, Inc. | Mitochondrial aldehyde dehydrogenase-2 binding compounds and methods of use thereof |
| EP3373977A4 (en) | 2015-11-12 | 2019-07-17 | The Board of Trustees of the Leland Stanford Junior University | CELLULAR PENETRATION-RICH GUANIDINIC OLIGOPHOSPHOTRIESTERS FOR THE DELIVERY OF MEDICATION AND PROBE |
| EP3377523A4 (en) | 2015-11-19 | 2019-06-19 | The Regents of The University of California | IMMUNITY CELL RECEIVERS REPRESSIBLE UNDER CONDITIONS AND METHODS OF USING THE SAME |
| EP3231421A1 (en) | 2016-04-11 | 2017-10-18 | Greenaltech, S.L. | Uses of a carotenoid in the treatment or prevention of stress induced conditions |
| WO2017189432A1 (en) | 2016-04-26 | 2017-11-02 | R.P. Scherer Technologies, Llc | Antibody conjugates and methods of making and using the same |
| MX2018014916A (es) | 2016-06-01 | 2019-07-18 | Servier Ip Uk Ltd | Formulaciones de oxido de polialquileno-asparaginasa y metodos de preparacion y uso del mismo. |
| BR112019014615A2 (pt) | 2017-01-18 | 2020-06-02 | F1 Oncology, Inc. | Receptores de antígeno quimérico contra axl ou ror2 e métodos de uso dos mesmos |
| EP3388082A1 (en) | 2017-04-13 | 2018-10-17 | Galera Labs, LLC | Combination cancer immunotherapy with pentaaza macrocyclic ring complex |
| EA202091832A1 (ru) | 2018-01-31 | 2021-01-11 | ГАЛЕРА ЛЭБЗ, ЭлЭлСи | Комбинированная терапия злокачественных новообразований макроциклическим кольцевым комплексом пентаазы и противоопухолевым агентом на основе платины |
| US11660266B2 (en) | 2018-04-11 | 2023-05-30 | Ohio State Innovation Foundation | Methods and compositions for sustained release microparticles for ocular drug delivery |
| MX2021000644A (es) | 2018-07-18 | 2021-08-19 | Manzanita Pharmaceuticals Inc | Conjugados para suministrar un agente contra el cancer a las celulas nerviosas, metodos de uso y metodos para la elaboracion de los mismos. |
| EP3946626A1 (en) | 2019-04-02 | 2022-02-09 | Kenjockety Biotechnology, Inc. | Efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto |
| MX2022009355A (es) | 2020-01-29 | 2022-09-02 | Kenjockety Biotechnology Inc | Anticuerpo anti-mdr1 y uso del mismo. |
| US20230212305A1 (en) | 2020-06-04 | 2023-07-06 | Kenjockety Biotechnology, Inc. | Anti-abcg2 antibodies and uses thereof |
| EP4161564A1 (en) | 2020-06-04 | 2023-04-12 | Kenjockety Biotechnology, Inc. | Abcg2 efflux pump-cancer antigen multi-specific antibodies and compositions, reagents, kits and methods related thereto |
| CA3193588A1 (en) | 2020-09-02 | 2022-03-10 | Kenjockety Biotechnology, Inc. | Anti-abcc1 antibodies and uses thereof |
| CA3203652A1 (en) | 2020-11-13 | 2022-05-19 | William Robert ARATHOON | Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof |
| AU2022413942A1 (en) | 2021-12-13 | 2024-05-30 | William Robert Arathoon Living Trust Dated August 29, 2016 | Anti-abcb1 antibodies |
| WO2023159220A1 (en) | 2022-02-18 | 2023-08-24 | Kenjockety Biotechnology, Inc. | Anti-cd47 antibodies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1997015571A1 (en) * | 1995-10-27 | 1997-05-01 | The Scripps Research Institute | Method for treating cancer using taxoid onium salt prodrugs |
| JP2002500667A (ja) * | 1997-05-27 | 2002-01-08 | ベーカー ノートン ファーマシューティカルズ インコーポレイテッド | 人間の患者に対して経口的にタキサン類を投薬するための方法及び組成物 |
-
1997
- 1997-06-20 WO PCT/US1997/010746 patent/WO1998058927A1/en not_active Application Discontinuation
- 1997-06-20 EP EP97932226A patent/EP1001769B1/en not_active Expired - Lifetime
- 1997-06-20 HU HU0002521A patent/HUP0002521A3/hu unknown
- 1997-06-20 JP JP50434699A patent/JP2002505682A/ja not_active Ceased
- 1997-06-20 CA CA002294606A patent/CA2294606A1/en not_active Abandoned
- 1997-06-20 IL IL13358597A patent/IL133585A0/xx unknown
- 1997-06-20 DE DE69713526T patent/DE69713526D1/de not_active Expired - Lifetime
- 1997-06-20 AU AU35740/97A patent/AU3574097A/en not_active Abandoned
- 1997-06-20 SK SK1825-99A patent/SK182599A3/sk unknown
- 1997-06-20 AT AT97932226T patent/ATE219363T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| DE69713526D1 (de) | 2002-07-25 |
| AU3574097A (en) | 1999-01-04 |
| ATE219363T1 (de) | 2002-07-15 |
| CA2294606A1 (en) | 1998-12-30 |
| EP1001769A1 (en) | 2000-05-24 |
| IL133585A0 (en) | 2001-04-30 |
| SK182599A3 (en) | 2000-07-11 |
| EP1001769B1 (en) | 2002-06-19 |
| JP2002505682A (ja) | 2002-02-19 |
| WO1998058927A1 (en) | 1998-12-30 |
| HUP0002521A2 (hu) | 2001-06-28 |
| EP1001769A4 (en) | 2000-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0002521A3 (en) | Onium salts of paclitaxel, process for producing them and medicaments comprising the same | |
| HUP0004422A3 (en) | 2-aryl-8-oxohydropurine derivatives, process for producing them, medicaments containing the same | |
| HUP0003073A3 (en) | Benzenesulfonamide derivatives, process for producing them and their use as medicines | |
| HUP0401081A3 (en) | Novel 1,2-diphenzylazetidinones, method for producing the same, medicaments containing said compounds, and their use | |
| EP1022284A4 (en) | TAXOID DERIVATIVES AND METHOD FOR THEIR PRODUCTION | |
| HUP0004102A3 (en) | Adenosine derivatives, process for producing them, medicaments comprising the same as active agent and their use for producing pharmaceuticals | |
| HUP0204170A3 (en) | 5-thia-omega-substituted phenyl-prostaglandin e derivatives, process for producing the same and drugs containing the same as the active ingredient | |
| EP0985697A4 (en) | OXIRANNE DERIVATIVES AND THEIR PRODUCTION PROCESS | |
| HUP9801688A3 (en) | Acetamide derivatives, process for producing the same, and medicinal composition containing the same | |
| HUP0000941A3 (en) | Sulfamide derivatives, process for producing them, pharmaceutical compositions containing them and their use | |
| HUP9600549A3 (en) | N-(3-benzofuranyl)urea-derivatives, medicaments containing the same and process for producing them | |
| HUP0002718A3 (en) | Piperazine derivatives, process for their preparation and medicaments containing the same | |
| HRP20010115B1 (en) | Benzocycloheptenes, method for the production thereof, pharmaceutical preparations containing these compounds, and their use for producing medicaments | |
| AU8627898A (en) | Pyrimidin-2,4,6-trion derivatives, method for producing the same and medicinal products containing these compounds | |
| AU7961200A (en) | Urea derivative, process for producing the same, and medicine containing the urea derivative | |
| HUP9801766A3 (en) | 6-carboxamido dihydropyran derivatives, process for producing them and medicaments containing the same | |
| AU6926496A (en) | New cyclic guanidines, process for preparing the same and medicaments | |
| HRP960583B1 (en) | New phenylamidine derivatives, a process for preparing the same and their use as medicaments | |
| HUP0003148A2 (en) | Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9901376A3 (en) | 1-methylcarbapenem derivatives, their use, production thereof and medicaments containing the same | |
| HUP0003150A3 (en) | Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| HUP9903902A3 (en) | Bromotiacumicin compounds, process for producing them and medicaments containing the same | |
| HUP9600665A2 (en) | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation | |
| HUP0003829A3 (en) | Cyanoguanidine derivatives, process for producing them and pharmaceutical compositions containing them | |
| EP1020441A4 (en) | N-HETEROCYCLIC METHYL PROPYLAMINE DERIVATIVES, METHOD FOR THEIR PRODUCTION AND GERMIZIDE |